Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AC Immune
Research
Researchers receive $6.9M NIA grant for tau-targeting drug
The drug helps stabilize the connections between the Alzheimer’s-associated protein tau and microtubules, key structural components of nerve cells.
Darren Incorvaia
Aug 21, 2024 1:02pm
AC Immune sees 'landmark' potential in brain-penetrating ADC
Jul 31, 2024 10:00am
Takeda pays AC Immune $100M upfront for a ph. 2 Alzheimer's drug
May 13, 2024 5:51am
Roche’s Genentech returns Alzheimer’s assets to AC Immune
Jan 22, 2024 8:47am
Pfizer exec out the door—Chutes & Ladders
Jul 28, 2023 9:30am
Early data from AC Immune Alzheimer's vaccine suggest response
Jan 26, 2023 11:13am